INFIRST+

Serial Number 98390551
730

Registration Progress

Application Filed
Feb 4, 2024
Under Examination
Dec 10, 2024
Approved for Publication
Oct 29, 2024
Published for Opposition
Oct 29, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Dec 10, 2025 153 days

Trademark Image

INFIRST+

Basic Information

Serial Number
98390551
Deadline
December 10, 2025
Description
Statement of Use or 2nd Extension Due
Filing Date
February 4, 2024
Published for Opposition
October 29, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Jun 10, 2025
Application
Pending
Classes
005 010

Rights Holder

Infirst Healthcare Inc.

03
Address
8 Church Lane
2nd Floor
Westport, CT 06880

Ownership History

Infirst Healthcare Inc.

Original Applicant
03
Westport, CT

Infirst Healthcare Inc.

Owner at Publication
03
Westport, CT

Legal Representation

Attorney
Dean G. Stathakis

USPTO Deadlines

Next Deadline
153 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
December 10, 2025
Extension Available
Until December 10, 2025

Application History

18 events
Date Code Type Description
Jun 16, 2025 EISU I TEAS STATEMENT OF USE RECEIVED
Jun 10, 2025 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 10, 2025 EX1G S SOU EXTENSION 1 GRANTED
Jun 10, 2025 EXT1 S SOU EXTENSION 1 FILED
Dec 10, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 29, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 29, 2024 PUBO A PUBLISHED FOR OPPOSITION
Oct 9, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 21, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 20, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 20, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 20, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 8, 2024 GNRT F NON-FINAL ACTION E-MAILED
Sep 8, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 8, 2024 CNRT R NON-FINAL ACTION WRITTEN
Aug 28, 2024 DOCK D ASSIGNED TO EXAMINER
Mar 8, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 7, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment and prevention of cancer, cardiovascular, endocrine or hormonal, gastrointestinal, inflammatory, musculoskeletal, microbial, neurodegenerative, neurological, pain, respiratory, skin, urological conditions, diseases and disorders; Pharmaceutical preparations for inflammatory relief; pain relief medications; headache and migraine treatment preparations; Pharmaceutical preparations for fever relief and the treatment of cough and cold; Pharmaceutical preparations for the treatment of heartburn, upset stomach, gastroesophageal reflux, acid reflux, acid indigestion relief, abdominal and stomach bloating, pain, and excessive gas build-up relief; diarrhea relief medications; Pharmaceutical preparations for the treatment of anti-microbial, anti-viral, and anti-bacterial infections; burn relief medications; acne treatment medications for acne relief, allergy relief medications
Class 010
Insulin pumps; Medical devices for use in treating or diagnosing abnormal blood sugar levels and diabetes; Medical devices for use in treating or diagnosing abnormal blood sugar levels and diabetes with integrated recorded operating system software, sold as a unit; Microneedle dermal pens

Additional Information

Pseudo Mark
IN FIRST PLUS

Classification

International Classes
005 010